CD8A and ovarian carcinoma: Together, these data suggest that IP administration of RPE-mIL2 locally causes significant activation, expansion, and proliferation of cytotoxic immune cells and systemically induces expansion and proliferation of CD8+ T cells in mice with ovarian cancer.